Dr Quynh Dinh is a lecturer in Pharmaceutical Sciences at RMIT University. Dr Dinh's research focuses on understanding inflammatory pathways that contribute to the development of cognitive impairment in cardiovascular disease and dementia.

Keren Esther Kristina Mantik is a medical doctor from Indonesia and a PhD candidate at Inha University. Her research focuses on systemic metabolic dysfunction in Alzheimer’s disease, particularly adipose tissue biology and peripheral amyloid-β toxicity. She investigates how neurodegenerative diseases pathology influences adipose tissue and immune–metabolic crosstalk using in vitro, in vivo, and human cohort data. Keren is committed to bridging basic and clinical research and aims to advance translational strategies that can be translated into patient care.

Dr. Sudhir Chandra Sarangi is a clinical pharmacologist with expertise spanning Clinical Pharmacology, Neuropsychopharmacology, Pharmacovigilance, Drug Safety, Pharmacogenetics, Pharmacoeconomics, and Computational Pharmacology. He has contributed to over 50 research papers in indexed journals, 10 book chapters, and holds six patents, with an H-index of 16, i10-index of 21, and 606 citations. Dr. Sarangi has received multiple awards, including the Best Poster Award at ISCOMS 2024 (Groningen, The Netherlands) and Best Paper Awards at the Joint Annual Conference of the Indian Epilepsy Society and Indian Epilepsy Association (ECON 2021, 2023). He has been awarded bursaries from the 34th and 35th International Epilepsy Congresses and received ICMR International Travel support to attend the 33rd International Epilepsy Congress in Bangkok, Thailand. He serves as Deputy Coordinator of the Pharmacovigilance and Materiovigilance program at AIIMS, New Delhi, and is an executive committee member of the Indian Epilepsy Society. He is also a member of the SAE subcommittee of the Institute Ethics Committee and an inspector in the GLP program under NGCMA, DST, Government of India. Dr. Sarangi is an active member of the National Academy of Medical Sciences (India), Indian Epilepsy Society, Indian Pharmacology Society, Indian Society of Rational Pharmacotherapeutics, The Association of Physiologists & Pharmacologists of India, Society of Toxicology (India), Indian Society of Nanomedicine, and the Delhi Pharmacological Society.

Dr. Soumya S. Pattnaik is a Senior Resident in the Department of Pharmacology at AIIMS-CAPFIMS Centre, New Delhi, India, with eight years of research experience in pharmacology. Her research interests include neuropharmacology, clinical and basic pharmacology, drug repurposing, pharmacogenomics, and pharmacovigilance. She has authored twelve research papers in indexed journals and contributed a book chapter. At WCP, she will present findings from a randomized controlled trial investigating the effects of vitamin D supplementation on sleep quality in individuals with drug-resistant epilepsy, highlighting potential underlying mechanisms.

Dr Ajay Prakash is Deputy-Coordinator at the Pharmacovigilance Centre, PGIMER, and serves as Associate Editor of the Indian Journal of Pharmacology (IJP), the official journal of the Indian Pharmacological Society (IPS). He is Adjunct Faculty in the Department of Physical and Rehabilitation Medicine and the Department of Nephrology at PGIMER, Chandigarh, and a Member of the Innovation Council at PGIMER. Dr Prakash is also an Expert Member of the Committee for Formulary of India at the Indian Pharmacopoeia Commission (IPC), and serves on several human and animal ethics committees. He is an Executive Member (North) of the Indian Pharmacological Society (IPS) and has received the Prof. B. N. Ghosh Oration along with several international awards. His academic contributions include more than 410 research publications in international and national journals, authorship of five books, and over 151 book chapters. His research areas include Natural Products, Neurological Diseases (Alzheimer’s Disease, Parkinson’s Disease, Autism, Resistant Epilepsy, Stroke), In silico studies, Meta-analysis, and Pharmacogenomics.

Valeria Tapia is a Neuroscience Honours student in the Department of Pharmacology within the School of Biomedical Sciences at UNSW Sydney. She completed a three-year Bachelor of Science majoring in Neuroscience, before commencing her Honours candidature in June 2025, which is expected to conclude in April 2026. Her research focuses on the effects of clinical doses of acute and chronic caffeine exposure on key brainstem nuclei involved in cardiorespiratory regulation, including the retrotrapezoid nucleus, nucleus of the solitary tract and C1/A1 catecholaminergic cell groups. In October 2025, she presented her work at the ASCEPT Cardiovascular, Respiratory and Inflammation SIG Student Symposium, where she was awarded the prize for Best Five-Minute Presentation.